retatrutide ly3437943 clinical trial results (LY3437943) New retatrutide Phase 3 data

In combination with insulin (with or without metformin), sitagliptin provided significant improvements in A1C, FPG, and 2-hour PPG compared to placebo (Table 14)

The argument is not you violated the FD&C Act, but you lied to consumers by telling them this unapproved salt is the same as our approved drug

As these drugs become more popular for weight management and diabetes treatment, many users report distressing side effects

Trial Design Investigators enrolled adults with a history of major atherosclerotic cardiovascular disease or with clinical characteristics that conferred high predicted risk for a first event

3, 2025, p.m

Additionally, quality of life, measured by the Dermatology Life Quality Index (DLQI), improved significantly (from 12.3 2.8 to 9.7 6.9